Teriflunomide Tablet, Film Coated
Product Images NDC 31722-246

Product Visual Gallery

This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Teriflunomide (NDC 31722-246). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Camber Pharmaceuticals, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Figure1 (Figure1)

A line graph comparing Disability Progression Sustained for 12 weeks (%) over time (up to 108 weeks) in patients receiving placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide. The graph shows higher progression in placebo versus both Teriflunomide doses, with annotations indicating statistical significance for 14 mg compared to placebo.*

FDA Label Image

Figure2 (Figure2)

A line graph showing disability progression sustained for 12 weeks over time in weeks for placebo, 7 mg Teriflunomide, and 14 mg Teriflunomide groups. The graph compares the percentages of disability progression among the three groups, indicating differences in outcomes during the study period.*

FDA Label Image

Teriflunomide-14mg-cont-label (Teriflunomide 14mg Cont Label)

Teriflunomide Tablets 14 mg film-coated oral tablets, labeled for prescription use. The package contains 30 tablets, manufactured for Camber Pharmaceuticals, Inc. The label includes dosage guidance, a U.S. contact number, and storage instructions. The label also shows a barcode and manufacturing details by Annora Pharma Pvt. Ltd., India.*

FDA Label Image

Teriflunomide-7mg-cont-label (Teriflunomide 7mg Cont Label)

Label for Teriflunomide Tablets 7 mg film-coated tablets by Camber Pharmaceuticals, Inc. The label states the package contains 30 tablets and is for prescription use only. It includes dosing instructions, storage information, a barcode, manufacturer details Annora Pharma Pvt. Ltd., and pharmacist dispensing guidance. The label has a distinctive purple and white design with a pink unvarnished area marked 40x30 mm.*

FDA Label Image

Teriflunomide-camberlogo (Teriflunomide Camberlogo)

FDA Label Image

Teriflunomide-structure (Teriflunomide Structure)

Chemical structure diagram of the active ingredient teriflunomide, showing its molecular arrangement including aromatic rings, functional groups, and atoms such as fluorine, nitrogen, oxygen, and carbon.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.